|
|
CorMedix names Klausner CMO - ModernHealthcare.com |
 |
 |
ModernHealthcare.com
Klausner, board certified in nephrology and internal medicine, has served as chief medical officer since 2007 at biotech firm Nephrogenex, according to a CorMedix news release. Klausner succeeds former CorMedix CMO Dr. Mark Houser, whose employment
|
|
|
ASCO Update on Bone-Modifying Drugs in Metastatic Breast Cancer - Medscape |
|
|
Medscape
In addition, the toxicity profiles are different — for example, denosumab is associated with a risk for hypocalcemia, and zoledronic acid and pamidronate are associated with a risk for renal toxicity and require renal function monitoring.
|
|
Davita Stock Hits New 52-Week High (DVA) - TheStreet.com (blog) |
|
|
TheStreet.com (blog)
DaVita Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. The company has a P/E ratio of 20.1, equal to the average health services industry P/E
|
|
|
CDC: Hospital Central Line Infections Drop Significantly - California Healthline |
|
|
California Healthline
Meanwhile, CDC estimates dialysis facilities had about 37000 central line infections in 2008. Roberta Mikles -- a retired nurse and member of the California Department of Public Health advisory committee on health care-associated infections -- said
|
|
Rockwell Medical Schedules Investor Conference Call - IEWY News |
|
|
IEWY News
About SFP: SFP is a novel, investigational, continuous iron therapy in late-stage clinical development, designed to treat iron deficiency anemia in ESRD patients. In contrast to intravenous (IV) iron delivery, SFP is a proprietary, water-soluble iron
|
|
|
|
|
<< Start < Prev 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 Next > End >>
|
|
Page 1047 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
